These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2481164)
21. [Thrombolytic therapy in acute myocardial infarct]. von Essen R Z Gesamte Inn Med; 1987 Sep; 42(17):486-91. PubMed ID: 3120430 [TBL] [Abstract][Full Text] [Related]
22. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)]. Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P; Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839 [TBL] [Abstract][Full Text] [Related]
23. Unresolved issues after the available comparative trials of thrombolytic agents in acute myocardial infarction. Collen D Z Kardiol; 1993; 82 Suppl 2():119-23. PubMed ID: 8328188 [TBL] [Abstract][Full Text] [Related]
25. [Prescription of heparin in the acute phase of myocardial infarction: expected and observed benefits...]. Cador R; Weber S Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1479-84. PubMed ID: 9092406 [TBL] [Abstract][Full Text] [Related]
27. Use of beta adrenoceptor blockade during and after acute myocardial infarction. Sleight P Annu Rev Med; 1986; 37():415-25. PubMed ID: 2871805 [TBL] [Abstract][Full Text] [Related]
28. [Which anti-ischemic treatment can be prescribed during and after the acute phase of myocardial infarction?]. Delahaye F; Genoud JL; Colin C; Landrivon G; Ecochard R; Desseigne P; Pinzani A; André-Fouët X; Delaye J Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1567-74. PubMed ID: 1363772 [TBL] [Abstract][Full Text] [Related]
29. [Treatment with beta-blockers in patients with acute coronary syndrome]. Nozawa T; Inoue H Nihon Rinsho; 1998 Oct; 56(10):2612-6. PubMed ID: 9796327 [TBL] [Abstract][Full Text] [Related]
30. Beta-blockade after myocardial infarction: practical implications of major clinical trials. Rehnqvist N; Olsson G J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S10-4. PubMed ID: 2481157 [TBL] [Abstract][Full Text] [Related]
31. [Evaluation of treatments with beta-blockaders after myocardial infarction]. Haïat R; Roussin I; Leroy G Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1697-702. PubMed ID: 1363902 [TBL] [Abstract][Full Text] [Related]
32. [The treatment of myocardial infarct with streptokinase]. Valere PE; Tricot R Ann Anesthesiol Fr; 1978; 19(8):727-33. PubMed ID: 31117 [TBL] [Abstract][Full Text] [Related]
36. [Progress in the treatment of acute myocardial infarct]. Kaindl F; Zilcher H Acta Med Austriaca; 1976; 3(1):1-12. PubMed ID: 826102 [TBL] [Abstract][Full Text] [Related]
37. According to MIAMI and ISIS-I trials, can a general recommendation be given for beta blockers in acute myocardial infarction? Kjekshus JK Cardiovasc Drugs Ther; 1988 May; 2(1):113-9. PubMed ID: 2908718 [TBL] [Abstract][Full Text] [Related]
38. Intravenous nitroglycerin for acute myocardial infarction. Borzak S Henry Ford Hosp Med J; 1991; 39(3-4):206-9. PubMed ID: 1804825 [TBL] [Abstract][Full Text] [Related]
39. Interventions that potentially limit myocardial infarct size: overview of clinical trials. Yusuf S Am J Cardiol; 1987 Jul; 60(2):11A-17A. PubMed ID: 2887096 [TBL] [Abstract][Full Text] [Related]
40. Clinical management of the patient with an acute myocardial infarction. Woo MA Nurs Clin North Am; 1992 Mar; 27(1):189-203. PubMed ID: 1372120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]